|Bid||3.83 x 2000|
|Ask||7.77 x 100|
|Day's Range||4.11 - 4.44|
|52 Week Range||3.05 - 10.90|
|PE Ratio (TTM)||-0.99|
|Earnings Date||May 12, 2017 - May 15, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
Q1 2017 Cyclacel Pharmaceuticals Inc Earnings Call
BERKELEY HEIGHTS, N.J., May 11, 2017-- Cyclacel Pharmaceuticals, Inc. a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer ...
NEW YORK, NY / ACCESSWIRE / May 11, 2017 / Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) will be discussing their earnings results in their Q1 Earnings Call to be held May 11, 2017 at 4:30 PM Eastern ...